Figure 2
The flow of patients through regimens of therapy among extensive stage small-cell lung cancer patients in MDV cohort initiating therapy from 2019 to 2022.
The flow of patients through regimens of therapy among extensive stage small-cell lung cancer patients in MDV cohort initiating therapy from 2019 to 2022.
